Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

2.72
Delayed Data
As of 3:59pm ET
 -0.04 / -1.45%
Today’s Change
1.50
Today|||52-Week Range
5.44
-11.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues5.0M9.0M5.7M3.2M
 
 
 
 
 
Cost of Goods Sold392.7K1.5M264.9K62.2M
 
 
 
 
 
Depreciation And Amortization1.0M569.4K578.1K--
 
 
 
 
 
Operating ExpensesGross Income3.5M6.9M4.8M-59.0M
 
 
 
 
 
General Expenses35.1M42.5M51.0M--
 
 
 
 
Research And Development29.2M33.1M41.2M--
 
 
 
 
Total Operating Expenses36.5M44.6M51.9M62.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-31.6M-35.6M-46.2M-59.0M
 
 
 
 
 
Extraordinary Credit16.7M0.000.00--
 
 
Interest Expense On Debt----2.1M5.5M
 
 
 
Other Expenses2.6M938.009.8K318.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.2M-35.5M-48.1M-64.2M
 
 
 
 
 
Income Taxes-44.1K-7.8K-58.2K-5.1M
 
 
 
 
 
Minority Interest-104.8K-105.4K-121.6K-98.8K
 
 
 
 
 
Net Income-12.2M-35.4M-48.0M-59.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS78.0M84.6M93.3M94.8M
 
 
 
 
 
Shares To Calculate EPS Diluted78.0M84.6M93.3M94.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.42-$0.51-$0.62
 
 
 
 
 
EPS Diluted-$0.16-$0.42-$0.51-$0.62